CureVac doesn't rule out accelerated approval for COVID-19 vaccine
Go back to CureVac doesn't rule out accelerated approval for COVID-19 vaccine| Clearview Acquisitions, Inc. (NASDAQ: CVAC) | Delayed: 4.66 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.66 | 52 Week High | $2.10 | |||
| Open | $4.66 | 52 Week Low | $1.50 | |||
| Day High | $4.66 | P/E | N/A | |||
| Day Low | $4.66 | EPS | $-0.04 | |||
| Volume | 3,114,697 | |||||
